A new and sensitive method for the quantification of HBV cccDNA by real-time PCR. (Q53868287)

21 May 2018

title

A new and sensitive method for the quantification of HBV cccDNA by real-time PCR. (English)

1 reference

21 May 2018

author name string

Ming-Liang He

1 reference

21 May 2018

Ming-Liang He

1 reference

21 May 2018

Jun Wu

1 reference

21 May 2018

Ying Chen

1 reference

21 May 2018

Marie C Lin

1 reference

21 May 2018

George K K Lau

1 reference

21 May 2018

Hsiang-fu Kung

1 reference

21 May 2018

language of work or name

English

0 references

publication date

1 August 2002

1 reference

21 May 2018

Biochemical and Biophysical Research Communications

published in

1 reference

21 May 2018

volume

295

1 reference

21 May 2018

issue

1 reference

21 May 2018

page(s)

1102-1107

1 reference

21 May 2018

Hepatitis B virus biology

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

Hepatitis B infection in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

Reversion of duck hepatitis B virus DNA replication in vivo following cessation of treatment with the nucleoside analogue ganciclovir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

Molecular approaches to validate disinfectants against human hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

Quantitative analysis of hepatitis B virus DNA by real-lime amplification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

Clinical utility of viral quantification as a tool for disease monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

High-throughput HBV DNA and HCV RNA detection system using a nucleic acid purification robot and real-time detection PCR: its application to analysis of posttransfusion hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

Quantitative detection of hepatitis B virus DNA in serum by a new rapid real-time fluorescence PCR assay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

Quantitative detection of hepatitis B virus DNA by real-time nucleic acid sequence-based amplification with molecular beacon detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

Screening for HBV, HCV and HIV genomes in blood donations: shortcomings of pooling revealed by a multicentre study simulating real-time testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

Real-time RT-PCR for quantitation of hepatitis C virus RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

Quantitation of HCV RNA using real-time PCR and fluorimetry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

Quantitation of HIV-1 by real-time PCR with a unique fluorogenic probe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900813-6

10.1016/S0006-291X(02)00813-6

7 January 2021

Identifiers

DOI

1 reference

21 May 2018

1 reference

21 May 2018